1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV XNAS: NAMS

NewAmsterdam Pharma Company NV Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

Read More
25.81 -1.09 (-4.05%)
New 52W High today
1.7M
XNAS Volume

XNAS 11 Sep, 2025 3:17 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
9.3 / 100
Momentum Score
Technically Moderately Bullish
63.8 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
41
1Yr Price target upside is 58%
12 analysts

17

S

10

W

4

O

0

T

SWOT Analysis

NewAmsterdam Pharma Company NV Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..